Chemovator

Chemovator is the business incubator and early-stage investor of BASF and supports venture teams to turn great business proposals into scalable and investable business opportunities. We leverage the unique connection to BASF knowledge and domain expertise, ambitious founders, industry partners, universities, investors and the entrepreneurship ecosystem to create deep tech opportunities that truly matter for our industry. As an early-stage or pre-seed investor, we offer two different programs: Chemovator - Evolve as the intrapreneurship program for BASF employees, and Chemovator - Elevate, where we invest into visionary founders with ideas centered around sustainability, next generation materials and other groundbreaking areas. Data Protection: https://www.chemovator.com/data-protection/ Impressum: https://www.chemovator.com/impressum/

Armira

Armira is a leading investment holding focusing on direct equity investments in medium-sized, profitable family businesses and ambitious growth companies in DACH, Northern Italy and beyond. Armira is backed by an exclusive investor base of families, entrepreneurs and entrepreneurial capital for trusted partnerships with a long-term horizon.

Brand Capital, India

Brand Capital is the strategic investment arm of The Times Of India and a part of Bennett, Coleman & Co. Ltd. (BCCL). We work with young businesses in creating iconic brands for businesses by putting unmatched might of our media offerings along with our brand building expertise. At the core we engage with growth- oriented Indian entrepreneurs; established as well as new-gen; to provide funding for long- term advertisement solutions. Brand Estate, our realty-focused arm, helps to propel real-estate brands to top-of-mind by providing innovative brand-building solutions. Overall, our aim is to help businesses targeting similar consumer segments ride on the equity of our power brands. We also work closely with the investor and mentor eco-system through our initiatives like SCALEUP and PROPEL, that bring budding young businesses in deep contact with investors and experts to help develop strategic direction and access to capital. Most trusted brands in India and globally have an underlying common thread – a sustained Brand Building effort. At Brand Capital, our mission is to ideate, articulate and establish your business’ growth potential through the Branding prism. Through our unique and pioneering models, Brand Capital provides critical leverage for brand-led growth and value creation.

n47

N47 is a global venture firm. We invest when the product speaks loudest—before the buzz and the metrics, when the truest expression of potential is the product itself. That’s when we partner with bold builders, those who begin with insight and move with urgency, and help them grow from belief to scale. Headquartered in Silicon Valley, we back builders across the US, Europe, and Israel.

qiming venture partners

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston, and the San Francisco Bay Area. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Zhihu (NYSE: ZH, SEHK: 2390), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), New Horizon Health (SEHK:6606), Sanyou Medical (SHSE:688085), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE: 688520), Yuanxin Technology, Caidya, Belief BioMed, WeRide, Biren Technology, and UBTech, among many others.